Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Taysha Gene Therapies Inc...

    NASDAQ: TSHA · Real-Time Price · USD
    2.92
    -0.02 (-0.68%)
    At close: Aug 15, 2025, 3:59 PM
    2.98
    1.88%
    After-hours: Aug 15, 2025, 07:17 PM EDT

    Taysha Gene Therapies Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 8.33M 15.45M 2.5M n/a
    Cost of Revenue
    		 n/a n/a n/a 492K
    Gross Profit
    		 8.33M 15.45M 2.5M -492K
    Operating Income
    		 -91.46M -72.44M -162.45M -173.27M
    Interest Income
    		 6.94M 3.57M 249K 172K
    Pretax Income
    		 -89.3M -111.57M -166.01M -174.52M
    Net Income
    		 -89.3M -111.57M -166.01M -175.46M
    Selling & General & Admin
    		 28.95M 30.05M 37.36M 41.32M
    Research & Development
    		 66M 56.78M 91.17M 131.94M
    Other Expenses
    		 4.84M 1.06M 36.42M n/a
    Operating Expenses
    		 99.79M 87.89M 164.95M 173.27M
    Interest Expense
    		 102K 5M 3.8M 1.43M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 99.79M 87.89M 164.95M 173.27M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 250.13M 232.24M 175.81M 150.6M
    Shares Outstanding (Diluted)
    		 250.13M 232.24M 175.81M 150.6M
    EPS (Basic)
    		 -0.36 -0.96 -3.78 -4.66
    EPS (Diluted)
    		 -0.36 -0.96 -3.78 -4.66
    EBITDA
    		 -87.95M -105.2M -159.73M -172.78M
    EBIT
    		 -89.2M -106.57M -162.22M -173.27M
    Depreciation & Amortization
    		 1.25M 1.37M 2.49M 492K

    Add to Watchlist